BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2053856)

  • 61. [Detection of platelet-activating factor in nasal lavage fluid from patients with pollinosis and experimental animals with nasal allergy].
    Shirasaki H; Asakura K
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Mar; 93(3):420-7. PubMed ID: 2352050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Olfactory dysfunction in sinusitis with infiltration of numerous activated eosinophils.
    Haruna S; Otori N; Moriyama H; Nakanishi M
    Auris Nasus Larynx; 2006 Mar; 33(1):23-30. PubMed ID: 16293387
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD25 T-lymphocytes induce CD11b on eosinophils in allergic nasal mucosa.
    Horiguchi S; Hisamatsu K; Tasaka K
    Mediators Inflamm; 1995; 4(2):144-8. PubMed ID: 18475632
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Late phase nasal reactions--reviewed and revisited.
    Ferguson H; Davies RJ
    Respir Med; 1991 May; 85(3):247-9. PubMed ID: 1882116
    [No Abstract]   [Full Text] [Related]  

  • 65. Eosinophilic leucocytes in nasal allergy--movement of enzymes.
    Watanabe K; Hasegawa M; Saito Y; Takayama S
    Clin Allergy; 1977 May; 7(3):263-71. PubMed ID: 908123
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monoclonal antibody EG2 reactivity cannot be used as an immunohistochemical activation marker for eosinophils.
    Jahnsen FL; Brandtzaeg P
    J Leukoc Biol; 1995 Mar; 57(3):513-4. PubMed ID: 7884325
    [No Abstract]   [Full Text] [Related]  

  • 67. Day-night differences in mucosal plasma proteins in common cold.
    Greiff L; Akerlund A; Andersson M; Svensson C; Alkner U; Persson CG
    Acta Otolaryngol; 1996 Jan; 116(1):85-90. PubMed ID: 8820357
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Experimental vasomotor rhinitis.
    Krajina Z; Harvey JE; Ogura JH
    Acta Otolaryngol; 1972; 73(2):212-7. PubMed ID: 5015153
    [No Abstract]   [Full Text] [Related]  

  • 69. Inflammatory mechanisms underlying potentiation of effects of inhaled aeroallergens in response to nitrogen dioxide in allergic airways disease.
    Krishna MT; Holgate ST
    Clin Exp Allergy; 1999 Feb; 29(2):150-4. PubMed ID: 10051716
    [No Abstract]   [Full Text] [Related]  

  • 70. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy.
    Terada N; Konno A; Togawa K
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 2):629-42. PubMed ID: 8083472
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Infiltration and activation of eosinophils during the late phase response in subjects with nasal allergy--from a study of nasal lavage fluid].
    Terada N; Ito E; Sugiyama T; Togawa K; Konno A
    Arerugi; 1991 Mar; 40(3 Pt 1):181-90. PubMed ID: 2053856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantification of eosinophil cationic protein and eosinophils in nasal secretions of allergen-induced nasal inflammation.
    Wang DY; Clement P; Smitz J; De Waele M; Derde MP
    Allergol Immunopathol (Madr); 1994; 22(4):179-83. PubMed ID: 7976971
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
    de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
    Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nasal response to allergen challenge in patients with immediate asthmatic reaction.
    Palczynski C; Krakowiak A; Ruta U; Krajewska B; Rudzinski J; Gielec L; Górski P
    Allergol Immunopathol (Madr); 1996; 24(4):163-8. PubMed ID: 8939272
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induced sputum to assess airway inflammation: a study of reproducibility.
    Spanevello A; Migliori GB; Sharara A; Ballardini L; Bridge P; Pisati P; Neri M; Ind PW
    Clin Exp Allergy; 1997 Oct; 27(10):1138-44. PubMed ID: 9383253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways.
    Erjefält JS; Greiff L; Andersson M; Matsson E; Petersen H; Linden M; Ansari T; Jeffery PK; Persson CG
    Am J Respir Crit Care Med; 1999 Jul; 160(1):304-12. PubMed ID: 10390416
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.